NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information

Journal of Biomedical Informatics - Tập 40 - Trang 30-43 - 2007
Nicholas Sioutos1, Sherri de Coronado2, Margaret W. Haber3, Frank W. Hartel2, Wen-Ling Shaiu4, Lawrence W. Wright3
1Aspen Systems Corporation, USA
2National Cancer Institute Center for Bioinformatics, 6116 Executive Blvd., Suite 403, Bethesda, MD 20892-8335, USA
3National Cancer Institute Office of Communications, USA
4Management Systems Designers, Inc., USA

Tài liệu tham khảo

Hartel, 2002, Information standards within the National Cancer Institute, 135 Hubbard, 2001, Information systems in oncology, 3135 caBIG. Available at: <http://cabig.nci.nih.gov/>. Accessed October 14, 2004. Sittig, 1994, Grand challenges in medical informatics, J Am Med Inform Assoc, 1, 412, 10.1136/jamia.1994.95153429 Lindberg, 1993, The unified medical language system, Meth Inf Med, 32, 281, 10.1055/s-0038-1634945 U.S. Department of Health & Human Services. Federal Health Architecture. <http://www.hhs.gov/fedhealtharch/>. Accessed October 14, 2004. Rector A, Nowlan W, Glowinski A. Goals for concept representation in the GALEN project. In: Proc Annu Symp Comput Appl Med Care 1993:414–18. SNOMED International, College of American Pathologists. SNOMED CT. Available from: <http://www.snomed.org/snomedct/index.html/>. Accessed February 23, 2005. Bard, 2004, Ontologies in biology: design, applications and future challenges, Nat Rev Genet, 5, 213, 10.1038/nrg1295 Covitz, 2003, caCORE: A common infrastructure for cancer informatics, Bioinformatics, 19, 2402, 10.1093/bioinformatics/btg335 De Coronado, 2004, NCI Thesaurus: using science-based terminology to integrate cancer research results, Medinfo, 2004, 33 Hartel, 2005, Modeling a description logic vocabulary for cancer research, J Biomed Inform, 38, 114, 10.1016/j.jbi.2004.09.001 Hartel FW, Fragoso G, Ong K, Dionne R. Enhancing quality of retrieval through concept edit history. In: Musen M, editor. AMIA Annu Symp Proc 2003:279–83. The NCICB Core Infrastructure Group. Available at: <http://ncicb.nci.nih.gov/core/>. Accessed October 14, 2004. Welcome to the NCI Terminology Browser. Available at: <http://nciterms.nci.nih.gov/>. Accessed October 14, 2004. Available at: <ftp://ftp1.nci.nih.gov/pub/cacore/EVS/>. Accessed October 14, 2004. Golbeck, 2003, The National Cancer Institute’s Thesaurus and Ontology, J Web Semantics, 1, 75, 10.1016/j.websem.2003.07.007 Available at: <ftp://ftp1.nci.nih.gov/pub/cacore/EVS/ThesaurusSemantics/>. Accessed October 14, 2004. Maes, 2002, Marginal zone cell lymphoma: an update on recent advances, Histopathology, 40, 117, 10.1046/j.1365-2559.2002.01360.x Starostik, 2002, Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways, Blood, 99, 3, 10.1182/blood.V99.1.3 Dierlamm, 1999, The apoptosis inhibitor gene AP12 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas, Blood, 93, 3601, 10.1182/blood.V93.11.3601 Liu, 2001, Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy, Lancet, 357, 39, 10.1016/S0140-6736(00)03571-6 Alizadeh, 2000, Distinct types of diffuse large B-cell lymphoma identifies by gene expression profiling, Nature, 403, 503, 10.1038/35000501 Shipp, 2002, Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning, Nature Med, 8, 68, 10.1038/nm0102-68 Rosenwald, 2002, The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma, N Engl J Med, 346, 1937, 10.1056/NEJMoa012914 McLean, 1996, TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia, Blood, 88, 4252, 10.1182/blood.V88.11.4252.bloodjournal88114252 Borkhardt, 1997, Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials, Blood, 90, 571, 10.1182/blood.V90.2.571 Uckun, 2001, Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia, Leuk Lymphoma, 42, 41, 10.3109/10428190109097675 Kanerva, 2004, Favorable outcome in 20-year follow-up of children with very-low-risk ALL and minimal standard therapy, with special reference to TEL-AML1 fusion, Pediatr Blood Cancer, 42, 30, 10.1002/pbc.10417 Pui, 1998, Acute lymphoblastic leukemia, N Engl J Med, 339, 605, 10.1056/NEJM199808273390907 Heerema, 2000, Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes), J Clin Oncol, 18, 1876, 10.1200/JCO.2000.18.9.1876 Arico, 2000, Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia, N Engl J Med, 342, 998, 10.1056/NEJM200004063421402 Schrappe, 1998, Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome, Blood, 92, 2730 Ribeiro, 1997, Philadelphia chromosome-positive acute lymphoblastic leukemia in children: durable responses to chemotherapy associated with low initial white blood cell counts, Leukemia, 11, 1493, 10.1038/sj.leu.2400749 Rubnitz, 1998, Molecular genetics of childhood leukemias, J Pediatr Hematol Oncol, 20, 1, 10.1097/00043426-199801000-00001 Pui, 1991, Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases, Blood, 77, 440, 10.1182/blood.V77.3.440.440 Crist, 1990, Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t (1;19) (q23;p13): a Pediatric Oncology Group study, Blood, 76, 117, 10.1182/blood.V76.1.117.117 Hunger, 1996, Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: clinical features and molecular pathogenesis, Blood, 87, 1211, 10.1182/blood.V87.4.1211.bloodjournal8741211 2002 2000 Vitali, 2003, c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571, Int J Cancer, 106, 147, 10.1002/ijc.11187 Ricotti, 1998, c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells, Blood, 91, 2397, 10.1182/blood.V91.7.2397 Chute CG, Carter JS, Tuttle MS, Haber MW, Brown SH. Integrating pharmacokinetics knowledge into a drug ontology as an extension to support pharmacogenomics. Proc AMIA Symp 2003:170–74. Hirsch, 2005, Biomarkers for prediction of sensitivity to EGFR inhibitors in non-small cell lung cancer, Curr Opin Oncol, 17, 118, 10.1097/01.cco.0000155059.39733.9d Amador, 2004, An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors, Cancer Res, 64, 9139, 10.1158/0008-5472.CAN-04-1036 Pathways. Available at: <http://cgap.nci.nih.gov/Pathways/>. Accessed October 14, 2004. Hayamizu, 2005, The Adult Mouse Anatomical Dictionary: a tool for annotating and integrating data, Genome Biol, 6, R29, 10.1186/gb-2005-6-3-r29 Benson, 2005, GenBank, Nucleic Acids Res, 1, 33 Hamosh, 2005, Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders, Nucleic Acids Res, 1, 33 Bairoch, 2005, The Universal Protein Resource (UniProt), Nucleic Acids Res, 1, 33 Spackman KA, Campbell KE, Cote RA. SNOMED RT: a reference terminology for health care. Proc AMIA Annu Fall Symp 1997:640–44. Spackman KA, Campbell KE. Compositional concept representation using SNOMED: toward further convergence of clinical terminologies. Proc AMIA Symp 1998:740–44. Dolin, 2004, Kaiser Permanente’s convergent medical terminology, Medinfo, 2004, 346 Carter JS, Brown SH, Erlbaum MS, Gregg W, Elkin PL, Speroff T, et al. Initializing the VA medication reference terminology using UMLS Metathesaurus co-occurrences. Proc AMIA Symp 2002:116–20. Brown, 2004, VA national drug file reference terminology: a cross-institutional content coverage Study, Medinfo, 2004, 477 Rector AL, Rogers JE. Ontological issues in using a description logic to represent medical concepts: experience from GALEN: Part 1—Principles. IMIA WG6 Workshop: Phoenix, Arizona, Nov. 1999. Available at: <http://www.opengalen.org/info/IMIAWG6-1999.pdf/>. Zanstra, 1997, Using the GRAIL language for classification management, Stud Health Technol Inform, 43, 441 Rosse, 2003, A reference ontology for biomedical informatics: the Foundational Model of Anatomy, J Biomed Inform, 36, 478, 10.1016/j.jbi.2003.11.007 Michael J, Mejino Jr JL, Rosse C. The role of definitions in biomedical concept representation. Proc AMIA Symp. 2001; 463–67. Fodor, 1998, Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients, Am J Hum Genet, 63, 45, 10.1086/301903 Gaedigk, 2003, Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D642, in African American subjects, Clin Pharmacol Ther, 73, 575, 10.1016/S0009-9236(03)00067-5 Wan, 2001, Analysis of the CYP2D6 gene polymorphism and enzyme activity in Africa-Americans in Southern California, Pharmacogenetics, 11, 489, 10.1097/00008571-200108000-00004